Preferences and acceptance of colorectal cancer screening in Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2269-2276

  Saengow, Udomsak ^a   Chongsuwiwatvong, Virasakdi ^a   Geater, Alan ^a   Birch, Stephen ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Acceptance; Colorectal cancer; Preference; Screening; Thailand

Indexed keywords

ADENOMA; AGED; CANCER STAGING; CHEMISTRY; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FECES; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATIENT ATTITUDE; PATIENT PREFERENCE; PROCEDURES; PROGNOSIS; THAILAND;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PREFERENCE; PROGNOSIS; THAILAND;

EID: 84929161911     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2269     Document Type: Article

References (44)

1. Barouni M, Larizadeh MH, Sabermahani A, et al (2012). Markov's modeling for screening strategies for colorectal cancer. Asian Pac J Cancer Prev, 13, 5125-9.
2. Bressler B, Paszat LF, Chen Z, et al (2007). Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology, 132, 96-102.
3. Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94.
4. Centers for Disease Control and Prevention (2011). Vital signs: Colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep, 60, 884-9.
5. Choi KS, Jun JK, Lee HY, et al (2010). Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health, 10, 265.
6. Choi KS, Lee HY, Jun JK, et al (2012). Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol, 27, 1070-7.
7. Cole SR, Tucker GR, Osborne JM, et al (2013). Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust, 198, 327-30.
8. Gupta S, Halm EA, Rockey DC, et al (2013). Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med, 173, 1725-32.
9. Hanvoravongchai P (2013). Health financing reform in Thailand: toward universal coverage under fiscal constraints.
10. Hfocus (2013). Cabinet considering integration of 3 healthcare schemes for cancer treatments [Online]. Available: http://www.hfocus.org/content/2013/12/5734.
11. Hilmi I, Hartono JL, Goh K (2010). Negative perception in those at highest risk-potential challenges in colorectal cancer screening in an urban Asian population. Asian Pac J Cancer Prev, 11, 815-22.
12. Hol L, van Leerdam ME, van Ballegooijen M, et al (2010). Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut, 59, 62-8.
13. Honda K (2004). Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health, 94, 815-22.
14. Hong NS, Kam S (2014). Effectiveness of interventions to increase screening for gastric and colorectal cancer in Korea. Asian Pac J Cancer Prev, 15, 9147-51.
15. International Cancer Screening Network (2014). Inventory of colorectal cancer screening activities in ICSN countries, May 2008 [Online]. Available: http://appliedresearch.cancer.gov/icsn/colorectal/screening.html [Accessed 9 January 2015].
16. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
17. Khuhaprema T, Sangrajrang S, Lalitwongsa S, et al (2014). Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open, 4, 003671.
18. Levi Z, Rozen P, Hazazi R, et al (2007). A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med, 146, 244-55.
19. Lisi D, Hassan C, Crespi M, et al (2010). Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Dig Liver Dis, 42, 371-6.
20. Major D, Bryant H, Delaney M, et al (2013). Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs. Curr Oncol, 20, 252-7.
21. Miller A (2007). Cancer control: knowledge into action: WHO guide for effective programmes: Module 3 Geneva, World Health Organization.
22. Misra T, Lalor E, Fedorak RN (2004). Endoscopic perforation rates at a Canadian university teaching hospital. Can J Gastroenterol, 18, 221-6.
23. Moss SM, Campbell C, Melia J, et al (2012). Performance measures in three rounds of the English bowel cancer screening pilot. Gut, 61, 101-7.
24. Nakama H, Zhang B, Zhang X (2001). Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer, 37, 398-401.
25. National Cancer Institute (2012). Cancer in Thailand: volume 6, 2004-2006, Bangkok.
26. National Cancer Institute (2013). National cancer control programmes (2013-2017), Bangkok, National Cancer Institute.
27. National Health Security Office (2014). Health insurance information service center [Online]. Available: http://eis.nhso.go.th/FrontEnd/Linkcontent.aspx?menu=530000001&pid=540000025 [Accessed 30/05 2014].
28. Nnoaham KE, Frater A, Roderick P, et al (2010). Do geodemographic typologies explain variations in uptake in colorectal cancer screening? An assessment using routine screening data in the south of England. J Public Health (Oxf), 32, 572-81.
29. Norwati D, Harmy MY, Norhayati MN, et al (2014). Colorectal cancer screening practices of primary care providers: results of a national survey in Malaysia. Asian Pac J Cancer Prev, 15, 2901-4.
30. Parente F, Boemo C, Ardizzoia A, et al (2013). Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy, 45, 27-34.
31. Pickhardt PJ, Choi JR, Hwang I, et al (2003). Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med, 349, 2191-200.
32. Popkin BM (1994). The nutrition transition in low-income countries: an emerging crisis. Nutr Rev, 52, 285-98.
33. Quintero E, Castells A, Bujanda L, et al (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med, 366, 697-706.
34. Rex DK, Cutler CS, Lemmel GT, et al (1997). Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology, 112, 24-8.
35. Shim JI, Kim Y, Han MA, et al (2010). Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat, 42, 191-8.
36. Suh M, Choi KS, Lee YY, et al (2013). Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev, 14, 6459-63.
37. Sun WY, Basch CE, Wolf RL, et al (2004). Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med, 39, 323-9.
38. Tastan S, Andsoy, II, Iyigun E (2013). Evaluation of the knowledge, behavior and health beliefs of individuals over 50 regarding colorectal cancer screening. Asian Pac J Cancer Prev, 14, 5157-63.
39. U. S. Preventive Services Task Force (2008). Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med, 149, 627-37.
40. Waye JD, Lewis BS, Yessayan S (1992). Colonoscopy: a prospective report of complications. J Clin Gastroenterol, 15, 347-51.
41. Wong MC, John GK, Hirai HW, et al (2012). Changes in the choice of colorectal cancer screening tests in primary care settings from 7, 845 prospectively collected surveys. Cancer Causes Control, 23, 1541-8.
42. Wong RK, Wong ML, Chan YH, et al (2013). Gender differences in predictors of colorectal cancer screening uptake: a national cross sectional study based on the health belief model. BMC Public Health, 13, 677.
43. Yusoff HM, Daud N, Noor NM, et al (2012). Participation and barriers to colorectal cancer screening in Malaysia. Asian Pac J Cancer Prev, 13, 3983-7.
44. Zhang J, Dhakal IB, Zhao Z, et al (2012). Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition. Eur J Cancer Prev, 21, 480-9.